|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2010-10-27
|
|
pubmed:abstractText |
Limited data suggest a benefit following sildenafil treatment in patients with pulmonary hypertension (PH) and interstitial lung disease (ILD). The role of sildenafil in the management of PH in ILD is not clear. We report our experience of ILD patients with PH after 6-month sildenafil therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1440-1843
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
© 2010 The Authors; Respirology © 2010 Asian Pacific Society of Respirology.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1226-32
|
|
pubmed:meshHeading |
pubmed-meshheading:20920139-Cohort Studies,
pubmed-meshheading:20920139-Exercise Test,
pubmed-meshheading:20920139-Female,
pubmed-meshheading:20920139-Humans,
pubmed-meshheading:20920139-Hypertension, Pulmonary,
pubmed-meshheading:20920139-Lung Diseases, Interstitial,
pubmed-meshheading:20920139-Male,
pubmed-meshheading:20920139-Middle Aged,
pubmed-meshheading:20920139-Natriuretic Peptide, Brain,
pubmed-meshheading:20920139-Piperazines,
pubmed-meshheading:20920139-Purines,
pubmed-meshheading:20920139-Sulfones,
pubmed-meshheading:20920139-Treatment Outcome,
pubmed-meshheading:20920139-Vasodilator Agents,
pubmed-meshheading:20920139-Walking
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
The use of sildenafil to treat pulmonary hypertension associated with interstitial lung disease.
|
|
pubmed:affiliation |
Royal Brompton Hospital, London, UK.
|
|
pubmed:publicationType |
Journal Article
|
